Fibroblast-Restricted Inflammasome Activation Promotes Atrial Fibrillation and Heart Failure With Diastolic Dysfunction
JACC: Basic to Translational Science · 2025-07 · 10 (7) · 101244
DOI: 10.1016/j.jacbts.2025.02.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Basic to Translational Science, 2025-07. Verfasst von Luge Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Section of Cardiovascular Research), Baylor College of Medicine, Houston, Texas, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NHLBI, American Heart Association Inc.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Atrial fibrillation (AF) often coexists with heart failure, both involving inflammatory signaling and cardiac fibroblasts. To understand the role of fibroblast NLR family pyrin domain containing 3 (NLRP3) inflammasome in cardiac function, we found that NLRP3 was up-regulated in atrial fibroblasts from AF patients. Fibroblast-specific activation of NLRP3 in mice induced AF-promoting atrial myopathy and heart failure with diastolic dysfunction, accompanied by increased fibrosis, and reduced conduction velocity. Knockdown of NLRP3 prevented the AF-promoting atrial substrate and cardiomyopathy in the context of NLRP3 activation in fibroblasts. We identify the fibroblast NLRP3 inflammasome as a key pathway governing the promotion of proarrhythmic fibrosis in AF and cardiomyopathy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine (Section of Cardiovascular Research), Baylor College of Medicine, Houston, Texas, USA.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
- Institute of Pharmacology, University Duisburg-Essen, Essen, Germany.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
- Center for Cardiovascular Research, University of Hawaii, Honolulu, Hawaii, USA.
Förderung
- NHLBI NIH HHS
- NHLBI
- American Heart Association Inc
Zitieren
APA
Li, L., Coarfa, C., Yuan, Y., Abu-Taha, I., Wang, X., Song, J., Zeng, Y., Chen, X., Koirala, A., Grimm, S. L., Kamler, M., McClendon, L. K., Tallquist, M., Nattel, S., Dobrev, D., & Li, N. (2025). Fibroblast-Restricted Inflammasome Activation Promotes Atrial Fibrillation and Heart Failure With Diastolic Dysfunction. JACC: Basic to Translational Science, 10(7), 101244. https://doi.org/10.1016/j.jacbts.2025.02.004
Vancouver
Li L, Coarfa C, Yuan Y, Abu-Taha I, Wang X, Song J, et al. Fibroblast-Restricted Inflammasome Activation Promotes Atrial Fibrillation and Heart Failure With Diastolic Dysfunction. JACC: Basic to Translational Science. 2025;10(7):101244. doi:10.1016/j.jacbts.2025.02.004
BibTeX
@article{Li2025,
author = {Li, Luge and Coarfa, Cristian and Yuan, Yue and Abu-Taha, Issam and Wang, Xiaolei and Song, Jia and Zeng, Yuying and Chen, Xiaohui and Koirala, Amrit and Grimm, Sandra L and Kamler, Markus and McClendon, Lisa K and Tallquist, Michelle and Nattel, Stanley and Dobrev, Dobromir and Li, Na},
title = {Fibroblast-Restricted Inflammasome Activation Promotes Atrial Fibrillation and Heart Failure With Diastolic Dysfunction},
journal = {JACC: Basic to Translational Science},
year = {2025},
volume = {10},
number = {7},
pages = {101244},
doi = {10.1016/j.jacbts.2025.02.004}
}
EUVIMED